Biotech companies in the United States by days to cover

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Immunovant leads the 20 biotech companies in the United States ranked by days to cover, at 15.3, ahead of Scholar Rock Holding (13.6) and Krystal Biotech (12.2). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report.

Key facts

Companies ranked
20
First
Immunovant15.3
Median
6.8
Combined market value
$734.9B
Countries
1

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Biotech companies in the United States by days to cover
#CompanyDays to cover ↓Market capPriceToday1 yearPrice, 30 daysCountry
1ImmunovantIMVT · Health Care15.3$6.7B$32.52 1.96% down 46% up United States
2Scholar Rock HoldingSRRK · Health Care13.6$6.1B$50.37 4.94% up 26% up United States
3Krystal BiotechKRYS · Health Care12.2$9.4B$315.82 0.15% up 54% up United States
4ExelixisEXEL · Health Care11.7$16.1B$65.83 3.60% down 63% up United States
5CG OncologyCGON · Health Care11.0$7.3B$81.90 2.38% up 97% up United States
6ImmunityBioIBRX · Health Care10.8$7B$6.57 1.94% down 232% up United States
7Kymera TherapeuticsKYMR · Health Care10.5$10.2B$119.39 1.44% down 87% up United States
8Kodiak SciencesKOD · Health Care9.3$6.4B$97.90 0.09% up 399% up United States
9Revolution MedicinesRVMD · Health Care7.8$34.5B$159.43 0.24% down 129% up United States
10Halozyme TherapeuticsHALO · Health Care6.8$10.6B$93.04 2.88% down 39% up United States
11VaxcytePCVX · Health Care6.7$9.2B$58.36 0.27% down 23% up United States
12Adaptive BiotechnologiesADPT · Health Care6.1$4.5B$28.05 1.44% down 74% up United States
13Neurocrine BiosciencesNBIX · Health Care5.4$15.8B$156.59 3.85% down 17% up United States
14AmgenAMGN · Health Care5.0$237.4B$438.82 1.14% down 32% up United States
15RepligenRGEN · Health Care4.9$10.9B$170.29 1.38% down 12% up United States
16Twist BioscienceTWST · Health Care4.4$7.6B$111.62 4.07% down 346% up United States
17BiogenBIIB · Health Care4.0$36.5B$247.13 1.70% down 49% up United States
18Gilead SciencesGILD · Health Care3.2$206.6B$166.53 1.45% down 35% up United States
19Bio-TechneTECH · Health Care2.7$11.4B$72.70 0.07% down 24% up United States
20ModernaMRNA · Health Care1.8$80.7B$199.33 1.29% up 780% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. Days to cover is short interest divided by FINRA's average daily volume for the period, worked out here: FINRA's own printed figure is floored at 1 and capped at 999.99, so it is not used. A company with no average volume reported has no days to cover and is not ranked.

Questions and answers

Which biotech companies in the United States rank first by days to cover?

Immunovant (15.3), Scholar Rock Holding (13.6) and Krystal Biotech (12.2) are the top three of the 20 biotech companies in the United States ranked by days to cover as of the 30 Oct 2026 settlement date.

How many biotech companies in the United States are in this ranking?

20 are ranked by days to cover.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by days to cover have a combined market value of $734.9B as of the 30 Oct 2026 settlement date.

What does ranking by days to cover measure?

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Cite this page

Funkfolio, “Biotech companies in the United States by days to cover”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=days-to-cover

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.